Replies to post #538383 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

It is great enough. The helmet is of some benefit, but it will eventually be superseded by a superior therapy.

[Bill B]

JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

Journal Frequency and Access. JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives over 2.4 million online visits annually and more than 3.6 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.

Editorial Information. The journal’s acceptance rate is 13%. The median time to first decision is 2 days, and 43 days with review. The journal's Impact Factor is 33, one of the highest ranking among oncology journals.

[SkyLimit2022]

That is disinformation. JAMA is JAMA. Is there any basis for your claim that JAMA Oncology is not as rigorously peer reviewed?

[rizona]

BS

JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

[SkyLimit2022]

Optune was published in JAMA Oncology.

[CrashOverride]

Wrong.

[SkyLimit2022]

This is the most recent publication about Optune. It was published in JAMA Oncology—the open source network that you claim is inferior.



After the open network launched at JAMA in 2018, that is where Optune data were published of course.

[highwayman4life]

JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
The journal’s acceptance rate is 13%. The median time to first decision is 2 days, and 43 days with review. The journal's Impact Factor is 33, one of the highest ranking among oncology journals.
AMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

[Know-Fear]

TTF might have some neurons misfiring.

[Roman516]

JAMA Oncology is very rigorously peer reviewed.
"JAMA Oncology is a member of the JAMA Network family of journals, which includes JAMA, 11 JAMA Network specialty journals, and JAMA Network Open. JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year."

https://www.linkedin.com/showcase/jamaoncology#:~:text=JAMA%20Oncology%20is%20a%20member%20of%20the%20JAMA,Thursday%2C%20and%20in%2012%20print%2Fonline%20issues%20a%20year.

Have a great day and JAMA some turkey and stuffing

[GPha]

Lmfao I can't believe a strategist in a biopharmaceutical company for 20 years just said that. Man, that's funny.

[Roman516]

JAMA Oncology is prestigious, and they conducted a rigorous review of NWBO.